Key result
Empirical prophylactic treatment with a pacemaker or antiarrhythmic drugs did not prevent syncopal recurrences, which occurred in 42.9% and 25% of treated patients versus 25.6% of untreated patients.
Why the study?
Does empirical prophylactic treatment prevent syncopal recurrences or complications in patients with unexplained syncope and a negative electrophysiologic study?
Cohort (n=58)
Does empirical prophylactic treatment prevent syncopal recurrences or complications in patients with unexplained syncope and a negative electrophysiologic study?
In patients with unexplained syncope and a negative electrophysiologic study, syncopal recurrences are common but generally non-cardiac, sudden death is rare, and empirical prophylactic treatment does not appear to prevent complications.
Answers are grounded in this paper and cite their sources.
Empirical prophylaxis should not yet change practice in unexplained syncope after negative EPS; leaves open targeted strategies for high-risk subgroups.
Fifty-eight patients (29 M, 29 F, mean age 60.8 +/- 16 years) with unexplained syncope at the end of a complete clinical and electrophysiological evaluation, were followed for a mean period of 36.6 +/- 20.5 months (median: 30.5 months). Structural heart disease was present in 32 patients (55.2%). The standard ECG was normal in 24 (41.4%) and showed sinus bradycardia (greater than 40 m-1) and/or first degree AV block and/or intraventricular conduction disturbances in 29 patients (50%). During follow-up, recurrences of syncope were observed in 11 of 43 untreated patients (25.6%), three of seven electrically treated patients (42.9%) and two of eight pharmacologically treated patients (25%). The cause of these recurrences was cardiac in one (1.7%), non-cardiac in 10 (17.2%) and remained undetermined in five (8.6%). Sudden death occurred in only one patient (1.7%), who was receiving chronic amiodarone therapy. These results indicate that (1) syncopal recurrences may occur in an appreciable percentage of patients with unexplained syncope and a negative electrophysiologic study during a relatively long-term follow-up, (2) syncopal recurrences, when they occur, are generally due to a non-cardiac cause, (3) sudden death is an occasional and rare event in this patient population and (4) empirical prophylactic treatment with a permanent pacemaker or antiarrhythmic drugs does not usually prevent complications during the follow-up.
No takes yet. Share an insight, caveat, or question.
RAVIEL et al. (1989) conducted a cohort in Unexplained syncope with negative electrophysiologic study (n=58). Empirical prophylactic treatment (pacemaker or antiarrhythmic drugs) vs. Untreated was evaluated on Recurrences of syncope. Empirical prophylactic treatment with a pacemaker or antiarrhythmic drugs did not prevent syncopal recurrences, which occurred in 42.9% and 25% of treated patients versus 25.6% of untreated patients.
Synapse has enriched 10 related papers. Consider them for comparative context: